Few studies have examined the potential role of clozapine in treatment of agitation in dementia patients who have previously failed to respond to standard pharmacotherapy. We conducted a systematic chart review of all elderly patients admitted to our inpatient unit between 2001 and 2004. Of them, 16 dementia patients were treated with clozapine for treatment-resistant agitation, and their charts were blindly rated by 3 clinicians on the Clinical Global Impression (CGI) Scale, Brief Agitation Rating Scale (BARS), and the Cohen-Mansfield Agitation Inventory-Short Form (CMAI-SF). Overall, clozapine therapy seemed beneficial in treatment-resistant agitation in dementia patients. (J Geriatr Psychiatry Neurol 2007;20:178—182)
Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA.1997; 278:1363-1371.
2.
Finkel SI, Costa E., Silva J., Cohen G., Miller S., Sartorius N.Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr.1996; 8(Suppl 3):497-500.
3.
Burns A., Rabins P.Carer burden dementia. Int J Geriatr Psychiatry. 2000;15(Suppl 1):S9-S13.
4.
Dunkin JJ, Anderson-Hanley C.Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention. Neurology. 1998;51(Suppl 1):S53-S60.
5.
Steele C., Rovner B., Chase GA, Folstein M.Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry.1990;147:1049-1051.
6.
Stern Y., Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. JAMA.1997; 277:806-812.
7.
Wancata J., Windhaber J., Krautgarner M., Alexandrowicz R.The consequences of non-cognitive symptoms of dementia in medical hospital departments. Int J Psychiatry Med.2003; 33: 257-271.
8.
Sourial R., McCusker J., Cole M., Abrahamowicz M.Agitation in dementia patients in acute care hospital: prevalence, disruptiveness, and staff burden. Int Psychogeriatr. 2001;13:183-197.
9.
Schneider LS , Pollock VE, Lyness SAA metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc.1990 ;38:553-563.
10.
Sink KM, Holden KF, Yaffe K.Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA.2005;293:596-608.
11.
McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry.1991;52:411-414.
12.
Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis . Neurology. 2003;60:1756-1761.
13.
The Parkinson Study Group.Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med.1999;340:757-763.
14.
Kraus JE, Sheitman BBClozapine reduces violent behavior in heterogeneous diagnostic groups. J Neuropsychiatry Clin Neurosci.2005;17:36-44.
15.
Pitner JK, Mintzer JE, Pennypacker LC, Jackson CWEfficacy and adverse effects of clozapine in four elderly psychotic patients . J Clin Psychiatry.1995;56:180-185.
16.
Saltzman C.Clozapine in elderly psychotic patients. J Clin Psychiatry.1996;57:309.
17.
Sajatovic M. , Jaskiw G., Knoicki PE, Jurjus G., Kwon K., Ramirez LFOutcome of clozapine therapy for elderly patients with refractory primary psychosis. Int J Geriatr Psychiatry . 1997;12:553-558.
18.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatry Press; 1994.
19.
Cohen-Mansfield J., Billing N.Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc.1986;34:711-721.
20.
Guy W (ed.). Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology. Publication No. ADM 76—336. Rockville, MD: US Department of Health, Education and Welfare; 1976.
21.
Finkel SI, Lyons JS, Anderson RLA brief agitation rating scale (BARS) for nursing home elderly. J Am Geriatr Soc.1993;41:50-52.
22.
Cohen-Mansfield J.Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc.1986;34;722-727.
23.
Folstein MF , Folstein, SE, McHugh PRMini-Mental State: a practical method for grading the state of patients for the clinician. J Psychiatr Res.1975;12:189-198.
24.
Schneider LS , Tariot PN, Lyketsos CG, et al. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry.2001;9:346-360.
25.
Schneider LS, Tariot PN, Lebowitz B., McShane R.The NIMH Clinical Antipsychotic Trial of Intervention Effectiveness— Alzheimer's disease (CATIE-AD): an early look at outcomes. Symposium presented at: the 12th Congress of International Psychogeriatric Association; March 20-24, 2005; Stockholm , Sweden.
